Skip to content

Tag Archives: ttnp

Titan Reports Patient Enrollment In Phase III Study Of Probuphine® Is Ahead Of Schedule

Titan Pharmaceuticals, Inc.

Titan Initiates Confirmatory Phase 3 Study Of Probuphine(R) In The Treatment Of Opioid Addiction

Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction…